• Zoom In
  • Search
  • Search
2023 Proxy Statement
  • Print
  • Print
  • PrintPrint
  • Clickable Index
  • Clickable IndexClickable Index
  • Thumbnails
  • ThumbnailsThumbnails
  • Help
  • HelpHelp
Welcome to Meet the Board. Use the menu above or click on any name, qualification, or committee to learn more.
Age: 62
Director Since: 2017
President and CEO
Term Expires: 2026
Committees:
  • None


Age: 70
Director Since: 2014
Independent Director
Term Expires: 2026
Committees:


Age: 64
Director Since: 2021
Independent Director
Term Expires: 2025
Committees:


Age: 67
Director Since: 2011
Independent Director
Term Expires: 2026


Age: 67
Director Since: 2013
Independent Director
Term Expires: 2024
Committees:


Age: 61
Director Since: 2018
Independent Director
Term Expires: 2025


Age: 55
Director Since: 2017
Independent Director
Term Expires: 2024
Committees:


Age: 67
Director Since: 2004
Independent Director
Term Expires: 2024


Age: 53
Director Since: 2019
Independent Director
Term Expires: 2025


Age: 54
Director Since: 2022
Independent Director
Term Expires: 2026
Committees:


Age: 73
Director Since: 2013
Independent Chair of the Board
Term Expires: 2025


Board Commitment to Diversity
Diversity is a cornerstone value and priority for our Board.
Average Tenure
Gail K. Boudreaux
Age: 62
Director since: 2017
President and CEO
Three-year term to expire at the 2026 Annual Meeting of Shareholders
Education
M.B.A., Columbia Business School; B.A., Dartmouth College
Director Qualifications
Ms. Boudreaux brings significant CEO, healthcare industry, insurance, finance and technology experience to the Board from her chief executive and other executive positions with several healthcare and insurance organizations and participation in numerous associations in the healthcare industry. Ms. Boudreaux’s positions also provided her with regulatory and public policy experience due to the highly-regulated nature of these organizations. She also gained financial and technology experience through her service as a director and as a member of the audit committee and technology operations committee of several public companies, including a medical device company and a biotechnology company. In addition, she has gained ESG experience, including related to diversity, equity and inclusion (“DEI”) and climate matters, through her CEO role at Elevance Health.
Professional and Other Experience
  • Elevance Health, Inc., President and CEO (since 2017)
  • GKB Global Health, LLC, a healthcare consulting firm, Founder and CEO (2015-2017)
  • UnitedHealth Group Incorporated, a diversified healthcare company, Executive Vice President (2008-2015), and President (2008-2011) and CEO (2011-2014) of its subsidiary, UnitedHealthcare
  • Health Care Service Corporation, a health insurance company, Executive Vice President of External Operations (2005-2008) and President of Blue Cross and Blue Shield of Illinois (2002-2005)
  • Aetna Inc., a managed healthcare company, various leadership positions (1983-2002)
  • Director of the BCBSA, the National Institute for Health Care Management and the Central Indiana Corporate Partnership, member of The Business Roundtable and chair of the Business Council
Other Public Board Service
  • Target Corporation, a general merchandise retailer, Director (since 2021)
  • Zimmer Biomet Holdings, Inc., a medical device company, Director (2012-2021)
  • Xcel Energy, Inc., a utility holding company, Director (2012-2017)
  • Novavax, Inc., a biotechnology company, Director (2015-2017)

R. Kerry Clark
Age: 70
Director since: 2014
Independent Director
Three-year term to expire at the 2026 Annual Meeting of Shareholders
Committees:
Education
B. Commerce, Queens University
Director Qualifications
Mr. Clark has extensive CEO, healthcare industry, marketing and consumer insights, and finance experience through his positions as Chairman and CEO of a major healthcare services organization, and as a senior executive at an international consumer products company, where he served in several positions involving marketing, advertising and product development of healthcare and other consumer products. Also, he has healthcare experience through his service on a hospital’s board of directors and ESG experience, including related to DEI, through his roles as lead director and chair of the governance committee of a public company. Mr. Clark qualifies as an “audit committee financial expert” under the rules of the Securities and Exchange Commission (“SEC”).
Professional and Other Experience
  • Cardinal Health, Inc., a healthcare products and services company, Chairman and CEO (2007-2009) and President and CEO (2006-2007)
  • The Procter & Gamble Company (“Procter & Gamble”), a consumer products company, various positions (1974-2006) including Vice Chairman, Global Health, Baby & Family Care (2004-2006) and Vice Chairman & President, Global Market Development (2002-2004)
  • The Christ Hospital in Cincinnati, Ohio, Director (since 2009)
Other Public Board Service
  • General Mills, Inc., a consumer food products company, Director (since 2009)
  • Textron, Inc., an aircraft, defense and industrial products company, Director (since 2003)
  • Avnet, Inc., an industrial distributor of electronic components, enterprise computer and storage products, Director (2012-2019)

Susan D. DeVore
Age: 64
Director since: 2021
Independent Director
Term expires at the 2025 Annual Meeting of Shareholders
Committees:
Education
M.M., McGill University; B.A., University of North Carolina at Charlotte
Director Qualifications
Ms. DeVore brings extensive healthcare industry, CEO and executive leadership experience to the Board gained through her past President and CEO positions at a healthcare improvement company that serves thousands of hospitals and other healthcare providers. She also gained technology experience in connection with her oversight of the healthcare improvement company’s technology/services segment and regulatory experience due to its highly-regulated nature. In addition, Ms. DeVore has finance experience as a former partner and region and sector leader at Ernst & Young LLP. Ms. DeVore qualifies as an “audit committee financial expert.”
Professional and Other Experience
  • Premier, Inc., a healthcare improvement company, various roles from 2003 until June 2021, with the most recent as CEO (2019-2021) and President (2013-2019)
  • Premier Healthcare Solutions, Inc. (subsidiary of Premier, Inc.), President and CEO (2009-2019) and Director (2009-2021)
  • AdventHealth, a healthcare system, Director (since 2020)
  • Cap Gemini/Ernst & Young LLP, a management consulting company, various roles from 1988 until 2002, including VP and Sector Leader, Manufacturing/High Tech & Media/Entertainment Units (2001-2002) and Sector Leader, High Growth Middle Market Division, North America (2000-2001)
Other Public Board Service
  • Unum Group, a financial protection benefits company, Director (since 2018)
  • Premier, Inc., Director (2013-2021)

Robert L. Dixon, Jr.
Age: 67
Director since: 2011
Independent Director
Three-year term to expire at the 2026 Annual Meeting of Shareholders
Education
B.S., Georgia Institute of Technology
Director Qualifications
Mr. Dixon has extensive technology experience through his position as Global Chief Information Officer of a large public company, his ownership of a digital and information technology consulting business, and his service on the CIO advisory board for another large public company. He also has significant marketing and consumer insights experience through his senior positions at two large public companies, both of which have global retail consumer product focus. Mr. Dixon has ESG experience, including related to DEI and climate matters, through his role as chair of the governance committee of a public company and his several executive and academic board positions.
Professional and Other Experience
  • RD Factor, Inc., a digital and information technology consulting business, owner (since 2016)
  • PepsiCo, Inc., a food and beverages company, Senior Vice President (2016) and Senior Vice President and Global Chief Information Officer (2007-2016)
  • Procter & Gamble, various positions (1977-2007), including Vice President of Global Business Services (2005-2007)
  • International Business Machines Corporation, a technology and consulting company, CIO Advisory Board (2011-2017)
  • Georgia Institute of Technology, President’s Advisory Board (since 2017), the College of Computing Advisory Board (since 2019) and Trustee Emeritus of the Foundation (since 2017)
Other Public Board Service
  • Build-A-Bear Workshop, Inc., a specialty retailer, Director (since 2018)
  • Okta, Inc., an identity management platform, Director (since 2019)

Lewis Hay, III
Age: 67
Director since: 2013
Independent Director
Term expires at the 2024 Annual Meeting of Shareholders
Committees:
Education
M.S., Carnegie Mellon University; B.S., Lehigh University
Director Qualifications
Mr. Hay brings extensive CEO, finance and regulatory and public policy experience to the Board through his positions as CEO, Chairman and CFO of a large utility company which was subject to significant regulation and oversight. He also has ESG experience related to climate from his management of the utility’s expansion of renewable energy sources. In addition, Mr. Hay has marketing and consumer insights experience from his service as an officer of a large utility company and a director of a financial services company, and technology experience from his service as a director of an information technology company. Mr. Hay qualifies as an “audit committee financial expert.”
Professional and Other Experience
  • Clayton, Dubilier & Rice, LLC, a private equity investment firm, operating advisor (since 2014)
  • NextEra Energy, Inc. (“NextEra Energy”), an electricity-related services and renewable energy generator company, Executive Chairman (2012-2013), CEO (2001-2012), Chairman (2002-2012) and President (2001-2006)
  • Artera Services, LLC, a provider of integrated infrastructure services to natural gas and electric industries, Director (since 2018, including for its predecessor company, PowerTeam Services, LLC)
Other Public Board Service
  • L3Harris Technologies, Inc., a global aerospace and defense technology firm, Director (since 2019 and 2002-2019 for its predecessor company, Harris Corporation)
  • Capital One Financial Corporation, a financial services company, Director (2003-2019)
  • NextEra Energy, Director (2001-2013)

Bahija Jallal
Age: 61
Director since: 2018
Independent Director
Term expires at the 2025 Annual Meeting of Shareholders
Education
M.S. and Ph.D., I’Universite’ De Paris VI; Fellow, Max Planck Institute of Biochemistry
Director Qualifications
Ms. Jallal brings extensive healthcare industry experience to the Board gained through her several leadership positions at biopharmaceutical companies that provide new medicines to patients, including her current position of CEO at a multinational biotechnology company. In addition, Ms. Jallal has CEO and finance experience through her current position and her former position of President at a biologic research and development subsidiary of a large public company. These positions also provided her with regulatory and public policy experience due to the highly-regulated nature of the biopharmaceutical and biotechnology industries.
Professional and Other Experience
  • Immunocore Limited, a T-cell receptor biotechnology company, CEO (since 2019)
  • AstraZeneca PLC (“AstraZeneca”), a pharmaceutical and biopharmaceutical business, Executive Vice President (2013-2019)
  • MedImmune, a biotechnology business and a subsidiary of AstraZeneca, President (2013-2019), Executive Vice President, Research and Development (2010-2013) and various other research and development positions (2006-2010)
Other Public Board Service
  • Immunocore Limited, Director (since 2019)
  • Guardant Health, Inc., a precision oncology company, Director (2019-June 2022)

Antonio F. Neri
Age: 55
Director since: 2017
Independent Director
Term expires at the 2024 Annual Meeting of Shareholders
Committees:
Education
Bachillerato en Electronica, Escuela Nacional de Educacion Tecnica
Director Qualifications
Mr. Neri brings CEO and significant technology experience to the Board gained through his current position of President and CEO at a large, multinational enterprise information technology company and from holding several leadership positions at firms that provide technology solutions to the business and public sectors. Mr. Neri also gained finance and marketing and consumer insights experience from past positions where he was responsible for determining consumer needs, overseeing product and promotional campaigns and promoting, selling and distributing products. Mr. Neri qualifies as an “audit committee financial expert.”
Professional and Other Experience
  • Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”), a technology company, President and CEO (since 2018), President (2017-2018) and Executive Vice President and General Manager, Enterprise Group (2015-2017)
  • HP Inc., a technology company, various positions (1995-2015), including Senior Vice President and General Manager, Enterprise Group (2014-2015), Senior Vice President and General Manager, HP Networking Business Units (2014), Senior Vice President and General Manager, HP Servers (2013-2014) and Senior Vice President and General Manager, HP Technology Services (2011-2013)
Other Public Board Service
  • Hewlett Packard Enterprise, Director (since 2018)
  • H3C Technologies Co., LTD, an information technology company, Director (2016-2017)

Ramiro G. Peru
Age: 67
Director since: 2004
Independent Director
Term expires at the 2024 Annual Meeting of Shareholders
Education
B.S., University of Arizona
Director Qualifications
Mr. Peru brings significant executive leadership and finance experience to the Board as a former CFO of two public companies. Mr. Peru’s positions also included technology experience as Senior Vice President at a mining and manufacturing company, with responsibility for managing both information systems and technology and human resources. In addition, he has technology experience through his service on the board of directors of an oil and gas exploration and production company.
Professional and Other Experience
  • Swift Corporation, a transportation company, Executive Vice President and CFO (June-December 2007)
  • Phelps Dodge Corporation (“Phelps Dodge”), a mining and manufacturing company, various finance and accounting positions with Phelps Dodge and its affiliates (1979-2007) including Executive Vice President and CFO (1999-2007)
  • UNS Energy Corporation (“UNS Energy”), an electric and gas utility holding company and a subsidiary of Fortis Inc., a utility holding company, Director (since 2007)
  • Bluemedia, Inc., a large format printer, Director (since 2018)
Other Public Board Service
  • SM Energy Company, an oil and gas exploration and production company, Director (since 2014)
  • UNS Energy (publicly traded until August 2014), Director (2007-2014)
  • WellPoint Health Networks, Inc., Director (2003-2004)

Ryan M. Schneider
Age: 53
Director since: 2019
Independent Director
Term expires at the 2025 Annual Meeting of Shareholders
Education
Ph.D., Yale University; B.A., Williams College
Director Qualifications
Mr. Schneider brings significant CEO, COO, finance, marketing and consumer insights and technology experience to the Board from his current CEO position at a real estate services company. In addition, Mr. Schneider has finance experience through his past leadership positions at a financial services organization. These positions also provided him with regulatory and public policy experience through his oversight of compliance with consumer and safety regulations, and due to the highly-regulated nature of the banking industry. He also gained insurance industry experience when he was employed as a consultant by multiple insurance companies while at McKinsey & Company.
Professional and Other Experience
  • Anywhere Real Estate Inc. (formerly known as Realogy Holdings Corp.) (“Anywhere Real Estate”), a residential real estate services company, CEO and President (since December 2017), President and Chief Operating Officer (October-December 2017)
  • McKinsey & Company, an international consulting firm, Senior Advisor (2017)
  • Capital One Financial Corporation, a financial services company, various positions (2001-2017), including Senior Advisor (2016-2017) and President, Card Business (2007-2016)
  • Capital One Bank (USA) N.A., Director (2007-2016)
Other Public Board Service
  • Anywhere Real Estate, Director (since 2017)

Deanna D. Strable
Age: 54
Director since: 2022
Independent Director
Three-year term to expire at the 2026 Annual Meeting of Shareholders
Committees:
Education
B.A., Northwestern University; Fellow, Society of Actuaries
Director Qualifications
Ms. Strable brings extensive executive leadership, insurance industry and regulatory experience to the Board, gained through her CFO and other executive positions with a global financial services company. She also has healthcare industry experience from her role as President of an insurance solutions division of a financial services company that provides specialty health insurance products. In addition, Ms. Strable has significant finance and capital markets experience through her current position as CFO of a public company, with oversight responsibility for financial reporting, capital markets and corporate finance. Ms. Strable qualifies as an “audit committee financial expert.”
Professional and Other Experience
  • Principal Financial Group, Inc. (“Principal Financial”), a financial services company, Executive Vice President and CFO (since 2017)
  • Principal Financial, President, U.S. Insurance Solutions (2015-2017)
  • Principal Financial, various other actuarial and management positions (1990-2017)
  • United Way Worldwide, Director (since 2018 including for its predecessor entity, United Way USA)
Other Public Board Service
  • None

Elizabeth E. Tallett
Age: 73
Director since: 2013
Independent Chair of the Board Since: 2018
Term expires at the 2025 Annual Meeting of Shareholders
Education
B.S., University of Nottingham
Director Qualifications
Ms. Tallett brings significant CEO, finance, healthcare industry, insurance industry and marketing and consumer insights experience to the Board from her chief executive, other management and board positions in several healthcare, insurance and pharmaceutical organizations. These positions also provided her with regulatory and public policy experience due to the highly-regulated nature of these organizations. She also has ESG experience gained through her roles as a lead director and as a member of the governance committees of several public companies.
Professional and Other Experience
  • Independent consultant to healthcare companies (since 2015)
  • Hunter Partners, LLC, a healthcare consulting company, principal (2002-2015)
  • Transcell Technologies, Inc., a specialty pharmaceutical company, President and CEO (1992-1996)
  • Centocor Pharmaceuticals, a biotechnology company, President (1987-1992)
  • Parke-Davis, a pharmaceuticals company, various roles including member of the Executive Committee (1973-1987)
Other Public Board Service
  • Moderna, Inc., a biotechnology company, Director (since 2020)
  • Qiagen, N.V., a molecular diagnostics and life sciences company, Supervisory Director (since 2011)
  • Meredith Corporation, a media company, Director (2008-2021)
  • Principal Financial, a financial services company, Director (1992-2021; as lead director from 2007-2019)
  • Coventry Health Care, Inc., a health insurance company, Director (1998-2013, including serving as lead director)

CEO CEO

Contributes to the Board’s understanding of complex operations, business strategy and risk management and demonstrated leadership ability at the highest level

Board Commitment to Diversity
Diversity is a cornerstone value and priority for our Board.
Average Tenure
CEO COO / Executive Leadership

Contributes to the Board’s understanding of complex operations, business strategy and risk management and demonstrated leadership ability

Board Commitment to Diversity
Diversity is a cornerstone value and priority for our Board.
Average Tenure
CEO Insurance Industry

Contributes to the Board’s understanding of insurance operations and the industry’s complex regulatory requirements, as well as the competitive environment

Board Commitment to Diversity
Diversity is a cornerstone value and priority for our Board.
Average Tenure
CEO Finance / Capital Markets

Valuable for evaluating our financial reporting process, financial management and capital allocations (dividends/share repurchases/financings)

Board Commitment to Diversity
Diversity is a cornerstone value and priority for our Board.
Average Tenure
CEO Healthcare Industry

Contributes to the Board’s understanding of the providers of healthcare services and products and issues related to simplifying healthcare

Board Commitment to Diversity
Diversity is a cornerstone value and priority for our Board.
Average Tenure
CEO Marketing / Consumer Insights

Contributes to the Board’s understanding of changing market conditions and consumer trends and expectations

Board Commitment to Diversity
Diversity is a cornerstone value and priority for our Board.
Average Tenure
CEO Technology

Contributes to the Board’s understanding of technology, including the use of new technologies in providing our products and services, as well as cybersecurity risks

Board Commitment to Diversity
Diversity is a cornerstone value and priority for our Board.
Average Tenure
CEO Regulatory / Public Policy

Contributes to the Board’s understanding of complex regulatory and public policy issues facing us as a highly-regulated entity

Board Commitment to Diversity
Diversity is a cornerstone value and priority for our Board.
Average Tenure
CEO ESG

Contributes to the Board’s understanding of leading corporate governance practices and environmental and social sustainability initiatives

Board Commitment to Diversity
Diversity is a cornerstone value and priority for our Board.
Average Tenure
CEO Diversity

Gender and racial/ethnic diversity provide different perspectives to the Board to foster innovation and inclusion

Board Commitment to Diversity
Diversity is a cornerstone value and priority for our Board.
Average Tenure
Principal Responsibilities:
  • The Audit Committee represents and assists the Board in its oversight of our accounting, financial reporting and internal controls over financial reporting.
  • In its oversight of our financial statements and the independent audit thereof, the Audit Committee is responsible for the selection, evaluation and, where deemed appropriate, replacement of the independent registered public accounting firm, and for the evaluation of the independence of the independent registered public accounting firm.
  • The Audit Committee is directly involved in the selection of the auditor’s lead engagement partner.
  • The Audit Committee is also responsible for the oversight of our ethics and compliance program and Code of Conduct, as well as assisting the Board in overseeing the processes by which we identify, assess, monitor and manage our exposure to major risks. The Chief Compliance Officer facilitates our compliance program and reports independently to the Audit Committee. The Audit Committee regularly receives a detailed report from the Chief Compliance Officer regarding our compliance program activities.


The Audit Committee met separately at several meetings during 2022 with executive management (including the CFO and the Chief Legal Officer), the Chief Accounting Officer, the Chief Internal Audit Executive, the Chief Risk Officer, the Chief Compliance Officer and the independent registered public accounting firm.

The Board has determined that each of the members of the Audit Committee is “independent” as defined by the rules of the SEC and the NYSE listing standards. The Board has determined that each of the Audit Committee members is an “audit committee financial expert” as defined by the SEC’s rules.
Principal Responsibilities:
  • The Compensation and Talent Committee assists the Board in discharging its responsibilities relating to compensation and benefits provided to our executive officers (which are determined by the Compensation and Talent Committee in its sole discretion), including overseeing an assessment of the risks related to our compensation policies and practices. See “Corporate Governance — The Board’s Role and Responsibilities — Board Role in Risk Oversight — Assessment of Compensation- Related Risks.”
  • The Compensation and Talent Committee sets the compensation level of our CEO and other executive officers based on an evaluation of the executive’s performance in light of our goals and objectives.
  • The Compensation and Talent Committee may take into consideration when setting the compensation levels of the executive officers (other than the CEO) any recommendations of the CEO with respect to the other executive officers.
  • In addition, the Compensation and Talent Committee has engaged Willis Towers Watson US LLC (“WTW”), an outside compensation consultant, to assist in the evaluation of CEO and executive officer compensation, as authorized under its charter. Reporting directly to the Compensation and Talent Committee, WTW participates regularly in Compensation and Talent Committee meetings, reviews the Company's executive compensation strategy and programs to ensure appropriateness and market-competitiveness and advises on compensation trends and best practices. The Compensation and Talent Committee assessed the independence of WTW pursuant to, and based on the factors set forth in, the SEC’s and NYSE’s rules and concluded that no conflict of interest exists that would prevent WTW from independently advising the Compensation and Talent Committee.
  • The Compensation and Talent Committee reviews and discusses talent acquisition and talent retention, and also monitors our programs and practices related to workforce diversity and inclusion.

Compensation Committee Interlocks and Insider Participation:
All members of the Compensation and Talent Committee are “non-employee directors” within the meaning of Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and “independent” within the meaning of the NYSE listing standards. None of the Compensation and Talent Committee members is or has been an officer or employee of the Company or, during 2022, was involved in a related person transaction requiring disclosure under Item 404 of Regulation S-K. During 2022, none of our executive officers served as a member of the board of directors or compensation committee of any other company that had an executive officer serving on our Board or our Compensation and Talent Committee.
Principal Responsibilities:
  • The Governance Committee assists the Board in discharging its responsibilities relating to Board composition and evaluations, non-employee director compensation and corporate governance by identifying and recommending individuals for nomination as members of the Board, recommending to the Board the overall non-employee director compensation policy and developing and recommending to the Board a set of corporate governance guidelines.
  • The Governance Committee also is responsible for reviewing, at least annually, our political strategy, contributions and activities, including our Political Contributions & Related Activity Report, and overseeing compliance with our policies and procedures regarding political contributions and activities.
  • In addition, the Governance Committee monitors our corporate social responsibility and environmental sustainability initiatives (including climate-related matters) as set forth in our annual Impact Report, which is prepared in accordance with the SASB and TCFD frameworks.
  • The Governance Committee has directly engaged Compensation Advisory Partners LLC (“CAP”), an outside compensation consultant, to assist in the evaluation of director compensation, as authorized under its charter. CAP reports directly to the Governance Committee. During 2022, CAP advised the Governance Committee with respect to director compensation trends and leading practices, plan design and the reasonableness of director compensation. CAP does not provide any other services to the Company. The Governance Committee assessed the independence of CAP pursuant to, and based on the factors set forth in, the SEC’s and NYSE’s rules and concluded that no conflict of interest exists that would prevent CAP from independently advising the Governance Committee.

The Board has determined that each of the members of the Governance Committee is “independent” as defined by the NYSE listing standards.
Principal Responsibilities:
  • The Finance Committee assists the Board in fulfilling its responsibilities related to our capital structure, financial policies, financing strategies and financial condition.
  • The Finance Committee is responsible for approving our annual capital plan and reviewing the issuance and retirement of debt and other securities and our credit facilities, as well as reviewing investment and financial risk management strategies.
  • The Finance Committee provides guidance to the Board on significant policies and matters of financial corporate governance, including our use of capital, dividend policy, share repurchase program and credit ratings.
  • The Finance Committee reviews our external insurance risk management program and insurance coverage.
  • The Finance Committee also reviews proposed material mergers, acquisitions and divestitures, approving certain of these transactions subject to Board delegation, and reviews the performance of completed material mergers, acquisitions and divestitures.

The Board has determined that each of the members of the Finance Committee is “independent” as defined by the NYSE listing standards.
 
   ...Previous
Continue...   
WARNING: JavaScript is disabled. CLICK HERE for help.
  • Go to previous page
  • Go to previous page
Page 95 of 95
  • Go to next page
  • Go to next page